MASTER PRODUCT SALE AGREEMENTMaster Product Sale Agreement • September 26th, 2008 • Senesco Technologies Inc • Services-commercial physical & biological research • Pennsylvania
This MASTER PRODUCT SALE AGREEMENT (this “Agreement”) is entered into as of June 27, 2008 by and between Senesco Technologies Inc, a Delaware corporation having its principal place of business at 303 George Street, Suite 420, New Brunswick, NJ 08901 (“CUSTOMER”), and among VGXI, Inc., a Delaware corporation having an address of 2700 Research Forest Drive Suite 180, The Woodlands, Texas 77381, and VGX International, Inc. a Korean company having an address of Jung-Hun Building, #701, 944-1 Daechi 3-Dong, Gangnam-gu, Seoul, Korea, (collectively, “VGX”) with reference to the following facts:
MASTER PRODUCT SALE AGREEMENTMaster Product Sale Agreement • December 17th, 2008 • Biocancell Therapeutics Inc.
This MASTER PRODUCT SALE AGREEMENT (this “Agreement”) is entered into as of September 12, 2008 between BioCancell Therapeutics, Ltd., a corporation organized under the laws of the State of Israel, with a principal business address at Beck Science Center, 8 Hartom Street, Har Hotzvim, Jerusalem 97775 Israel (“CUSTOMER”), and VGXI USA, a business entity registered in the state of Texas, having an address at 2700 Research Forest Drive Suite 180, The Woodlands, Texas 77381, (“VGX”) a DBA of VGX International Inc. at 944-1 Daechi-dong, Kangnam-ku, Seoul, Korea, with reference to the following facts:
